CVS Health Corp (CVS)

Industry Healthcare Plans

This stock can be held in an Investment ISA and an Investment Account

Sell

$79.20

Buy

$79.51

arrow-down$-1.41 (-1.74%)

Prices updated at 13 Dec 2025, 00:59 EST

Prices minimum 15 mins delay

Prices in USD

CVS Health Corp operates in the healthcare sector. Its primary business is that of operating retail pharmacies. The company has three reportable segments namely Pharmacy Services, Retail/LTC, and Corporate.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Healthcare Plans

Chairman

Mr. Roger N. Farah

CEO

Mr. J. David Joyner

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

300,000

Head office

One CVS Drive

Woonsocket

United States

02895

+1 401 765-1500

investorinfo@cvshealth.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Brian O. Newman Executive Vice President and Chief Financial Officer	-
Dr. Amy Compton Phillips Executive Vice President and Chief Medical Officer	-
Mr. Fernando Aguirre Independent Director	0.09m
Mr. Guy P. Sansone Independent Director	0.04m
Mr. J. Scott Kirby Independent Director	0.00m
Mr. Roger N. Farah Executive Chairman of the Board	-
Mr. Steven H. Nelson Executive Vice President and President, Aetna	-
Mr. C. David Brown, II Independent Director	0.09m
Ms. Anne M. Finucane Independent Director	0.08m
Mr. J. David Joyner Director, President and Chief Executive Officer	1.10m
Ms. Leslie V. Norwalk, Esq. Director	0.04m
Mr. Michael F. Mahoney Lead Independent Director	0.08m
Mr. Samrat S. Khichi Executive Vice President, Chief Policy Officer and General Counsel	-
Ms. Alecia A. DeCoudreaux Independent Director	0.08m
Ms. Heidi B. Capozzi Executive Vice President and Chief People Officer	0.27m
Mr. Douglas H. Shulman Independent Director	0.04m
Dr. Jeffrey R. Balser, M.D.,PhD Independent Director	0.09m
Mr. James D. Clark Senior Vice President, Controller and Chief Accounting Officer.	-
Mr. Larry M. Robbins Independent Director	-
Mr. Tilak Mandadi Executive Vice President, Ventures and Chief Digital, Data, Analytics and Technology Officer	1.00m
Mr. Prem S. Shah Executive Vice President and Group President	0.97m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	120,399,131
BlackRock Inc	119,836,144
Capital Research and Management Company	105,010,655
Dodge & Cox	73,176,586
JPMorgan Chase & Co	70,550,472

Director dealings

Date chevron-l-regular chevron-r-regular	Action
05 Dec 2024	-
30 Nov 2024	-
30 Nov 2024	-
30 Nov 2024	-
30 Nov 2024	-
30 Nov 2024	-
30 Nov 2024	-
30 Nov 2024	-
30 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.